EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis

Hongqiong Zhao, Wei He, Chunyu Xia, Zhu Yang iD

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.15987 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Hongqiong Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Abortion, Threatened, Progestins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Threatened miscarriage is defined as early vaginal bleeding before 12 weeks of gestational age and can occur in any pregnancy regardless of maternal age, race, comorbidities, lifestyle, or socioeconomic status, and about one‐quarter of threatened miscarriages proceed to complete miscarriage. To assess the relative effectiveness and safety of different progestogens in women with first threatened miscarriage, using a network meta‐analysis. A systematic search was conducted in PubMed, EMBASE, and Cochrane Library databases from inception to April 2023. Randomized controlled trials (RCTs) assessing the effectiveness or safety of placebo or different progestogens for the treatment of threatened miscarriage were eligible for inclusion, including dydrogesterone (oral), progesterone (oral, vaginal, rectal), and 17‐α‐hydroxyprogesterone (intramuscular). A Bayesian network meta‐analysis with Markov chain Monte‐Carlo simulation was performed in this study. A pairwise meta‐analysis was carried out by synthesizing studies that compared the same interventions using a fixed‐effects model. The primary outcome was the percentage of miscarriage (defined as delivery before 24 weeks of gestation) and preterm birth (defined as birth before 37 weeks of gestation), and the secondary outcomes were live birth rate, congenital abnormalities, neonatal outcomes (low birth weight

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, ThreatenedProgestinsFemaleHumansPregnancy17-alpha-HydroxyprogesteroneBayes TheoremDydrogesteronePremature BirthProgesteroneRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

dydrogesteronemiscarriagenetwork meta‐analysisprogesteronethreatened miscarriage

Substanzen

17-alpha-HydroxyprogesteroneDydrogesteroneProgesteroneProgestins

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Gastroenterology, Chongqing Southeast Hospital, Chongqing, China.
  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Zhu Yang

Zitieren

APA

Zhao, H., He, W., Xia, C., & Yang, Z. (2025). Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15987

Vancouver

Zhao H, He W, Xia C, Yang Z. Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.15987

BibTeX
@article{Zhao2025,
  author = {Zhao, Hongqiong and He, Wei and Xia, Chunyu and Yang, Zhu},
  title = {Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.15987}
}
Kostenlos starten →